Increases in Heroin Use in the U.S. Greater Among Whites

Share this content:
Increases in Heroin Use in the U.S. Greater Among Whites
Increases in Heroin Use in the U.S. Greater Among Whites

THURSDAY, March 30, 2017 (HealthDay News) -- From 2001-2002 to 2012-2013 there was an increase in the prevalence of heroin use and heroin use disorder, according to a study published online March 29 in JAMA Psychiatry.

In an effort to examine changes in heroin use, Silvia S. Martins, M.D., Ph.D., from Columbia University in New York City, and colleagues used data from 43,093 respondents of the 2001 to 2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) and 36,309 respondents of the 2012 to 2013 NESARC-III.

The researchers observed a significant increase in the prevalence of heroin use and heroin use disorder from 2001-2002 to 2012-2013 (use, 0.33 to 1.6 percent; disorder 0.21 to 0.69 percent; P < 0.001). The increase in prevalence of heroin use was more pronounced among white versus nonwhite individuals (0.34 to 1.90 percent versus 0.32 to 1.05 percent; P < 0.001). The increase in the prevalence of heroin use disorder was greater for white individuals (0.19 to 0.82 percent; P < 0.001) than nonwhites (0.25 to 0.43 percent) and for those aged 18 to 29 years (0.21 to 1.0 percent; P = 0.01) and 30 to 44 years (0.20 to 0.77 percent; P = 0.03) than older adults (0.22 to 0.51 percent).

"Findings highlight the need for educational campaigns regarding harms related to heroin use and the need to expand access to treatment in populations at increased risk for heroin use and heroin use disorder," the authors write.

One author disclosed ties to Inventive Health Consulting, which combines support from nine pharmaceutical companies.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »